ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

NCI Cooperative Groups Recognized By ASCO For 50+ Years Of Clinical Trials.

June 1, 2007